By Kim Shuske
http://stream.publicbroadcasting.net/production/mp3/kuer/local-kuer-863230.mp3
Salt Lake City, UT – The first arguments are being heard today in a case that has broad implications for genetic research, drug makers, and patent holders. Salt Lake City based company Myriad Genetics is being sued by the American Civil Liberties Union which claims it unconstitutionally patented high-risk breast cancer genes, thus preventing other researchers from studying them. The lawsuit was filed on behalf of four scientific organizations representing more than 150,000 geneticists, researchers, and women with breast cancer. Kim Schuske reports. (Sheri Quinn was a contributing reporter for this story.)
American Civil Liberties Union webpage on gene patent lawsuit
Myriad Genetics corporate website